Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Urol. Nov 24, 2014; 3(3): 364-369
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.364
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.364
Ref. | Adverse effects (n) |
Gelbard et al[22] | Ecchymosis (21), Pain (2), Albuginea rupture (1) |
Gelbard et al[23] | Tenderness at injection site (Majority), tunica albuginea rupture (1) |
Jordan[24] | Edema/pain/or ecchymosis (20), No serious AEs |
Gelbard et al[25] | Bruising (96), Edema (50), Pain (58), No serious AEs |
Gelbard et al[26] | Ecchymosis (441), Edema (30), Pain (250), Corporeal rupture (3), Penile hematoma (3) |
- Citation: Marchalik D, Wright H, Hill F, Vora A. Use of intralesional collagenase in the treatment of peyronie’s disease: A review. World J Clin Urol 2014; 3(3): 364-369
- URL: https://www.wjgnet.com/2219-2816/full/v3/i3/364.htm
- DOI: https://dx.doi.org/10.5410/wjcu.v3.i3.364